Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II: Safety and Primary Efficacy of Clinical Application of Newcastle Disease Virus for the Treatment of Patients Resistant to All Conventional Modalities

NCT00348842 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00348842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00348842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II: Safety and Primary Efficacy of Clinical Application of Newcastle Disease Virus for the Treatment of Patients Resistant to All Conventional Modalities
Lead sponsor
Hadassah Medical Organization
Phase
Phase 2
Overall status
Withdrawn
Start date
March 31, 2006
Completion date
June 30, 2006
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, newcastle disease virus (ndv)